RLX Technology Inc. (NYSE: RLX)

Sector: Consumer Defensive Industry: Tobacco CIK: 0001828365
Market Cap 362.31 Mn
P/E 6.07
P/S 0.65
Div. Yield 0.04
ROIC (Qtr) 0.00
Total Debt (Qtr) 12.99 Mn
Revenue Growth (1y) (Qtr) 46.44
Add ratio to table...

About

RLX Technology Inc is a leading global branded e-vapor company engaged in the full spectrum of activities in the e-vapor industry including scientific research technology and product development supply chain management and distribution of products to adult smokers worldwide. The company leverages its strong in-house technology and product development capabilities and deep insights into adult smokers needs to develop superior e-vapor products across closed-system rechargeable disposable and open system categories. Since its inception in 2018 RLX...

Read more

Investment thesis

Bull case

  • RLX’s recent quarter showcased a 49% year‑over‑year revenue surge, underpinned by a 70‑80% share of international sales, signaling a robust global footprint that dwarfs its domestic base. The company’s disciplined expansion into Asia Pacific via a franchise retail model amplified same‑store sales growth, proving the effectiveness of a unified brand strategy that elevates consumer experience and operational control. Coupled with a strong cash position of RMB16.4 billion, RLX can pursue strategic acquisitions or roll out new product categories without over‑leveraging, ensuring financial flexibility. These dynamics point to a high upside, as the firm continues to scale efficiently while maintaining healthy margins and shareholder returns.
  • The launch of the modern oral product in Intertek, Germany, marks the entry into the smokeless segment, a growth niche that is projected to eclipse traditional e‑vapor volumes over the next decade. RLX’s ultra‑thin, fast‑absorbing design has already gained industry validation, positioning the company to capture a premium share early in the life cycle. By phasing rollout, the company can collect granular market data, fine‑tune product positioning, and potentially achieve higher unit economics as consumer adoption accelerates. This forward‑moving product pipeline is a hidden catalyst that management has not heavily emphasized, yet it promises significant upside if the broader smokeless trend continues to materialize.
  • R&D investment remains a cornerstone of RLX’s differentiation strategy, with a focus on flavor authenticity, device ergonomics, and aesthetic design that resonates across diverse markets. The company’s East Asia product launch set industry benchmarks for disposable e‑vapor design, indicating a rapid innovation cycle that keeps RLX ahead of competitors who lag behind on consumer‑centric development. A disciplined R&D spend, tied to product launch success, mitigates the risk of cannibalization and ensures new offerings drive incremental top‑line growth rather than merely replacing existing lines. This strategic focus on meaningful product evolution strengthens RLX’s brand equity and reduces churn, reinforcing long‑term profitability.
  • RLX’s capital allocation framework prioritizes shareholder returns through share repurchases and dividends, while simultaneously preserving a sizable cash reserve for reinvestment. By returning over $500 million since IPO and declaring a quarterly dividend, RLX signals confidence in its cash flow generation, attracting income‑oriented investors. At the same time, the firm’s robust cash flow—from RMB350 million operating cash flow in Q3—provides the buffer needed to absorb regulatory shocks or to seize opportunistic acquisitions, maintaining a flexible growth trajectory. This balance between value creation and growth capital is a rare attribute that can sustain momentum in a volatile industry.
  • Regulatory dynamics, while presenting headwinds, also create a structural advantage for compliant brands like RLX. The tightening of enforcement against illegal online sales has already started shifting consumer preference toward legitimate, quality‑controlled products, thereby expanding the addressable market for RLX’s brand. The company’s active advocacy for regulatory adjustments around flavor formulations further positions it as an industry steward, potentially shaping policy in its favor. Consequently, as the market matures and cleans up, RLX’s compliance posture could translate into a first‑mover advantage, reinforcing its leading position in the e‑vapor sector.
Read more

Bear case

  • Despite robust international revenue, RLX’s domestic footprint remains a fraction of its global earnings, with Mainland China revenue at only 13% of 2021 levels. The persistent unregulated electric e‑vapor market distorts competition and suppresses volume recovery, creating a long‑term upside ceiling in a country that hosts a sizable share of global consumers. Management’s acknowledgment that “true market order can only be achieved through consistent enforcement actions” signals a reliance on external regulatory developments beyond the company’s control, leaving RLX exposed to prolonged stagnation if enforcement remains uneven.
  • The company’s reliance on a sizeable equity stake in a European e‑vapor firm introduces integration and valuation risk. While the European investment has contributed to Q3 earnings, the integration process is “in the early stages” and subject to operational and cultural challenges that could erode expected synergies. Moreover, the UK disposable product ban has forced RLX to pivot to reusable formats, potentially cannibalizing high‑margin disposable sales and necessitating costly product redesigns. These regulatory and integration uncertainties could strain capital and divert managerial focus from core growth initiatives.
  • RLX’s channel innovation strategy—unifying independent vape stores under a franchise model—relies heavily on a large partner base that may be sensitive to economic cycles and competitive pressures. While the model has driven revenue growth in select markets, the scalability of this approach across new territories remains unproven, especially in regions with more entrenched retail ecosystems or tighter regulatory oversight. A failure to replicate the franchise success could limit the company’s ability to penetrate high‑potential markets, exposing it to incremental growth risks.
  • The modern oral segment, though promising, is still nascent and has limited proven revenue traction beyond initial validation in Intertek, Germany. The company’s near‑term expectations are “prudent” as it builds market data, implying that the segment may not yet be a significant driver of top‑line growth. Until a robust demand base and a proven distribution network materialize, the modern oral launch represents a speculative allocation of R&D and capital that could dilute focus from the core e‑vapor business.
  • RLX’s strong liquidity position, while a defensive asset, could also incentivize a high level of share repurchase activity that reduces available capital for organic growth or strategic acquisitions. The company’s track record of returning nearly all profits to shareholders suggests a possible short‑term bias toward dividend yield rather than long‑term value creation. In a rapidly evolving industry, this approach might leave RLX ill‑positioned to invest in emerging technologies or to weather unforeseen competitive disruptions, ultimately constraining its future upside.
Read more

Peer comparison

Companies in the Tobacco
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 PM Philip Morris International Inc. 298.46 Bn 26.94 7.19 49.50 Bn
2 MO Altria Group, Inc. 121.13 Bn 15.11 5.17 24.60 Bn
3 BTI British American Tobacco p.l.c. 51.25 Bn 14.30 1.50 46.65 Bn
4 TPB Turning Point Brands, Inc. 1.76 Bn 30.25 3.65 0.29 Bn
5 UVV Universal Corp /Va/ 1.35 Bn 15.85 0.46 1.08 Bn
6 RLX RLX Technology Inc. 0.36 Bn 6.07 0.65 0.01 Bn
7 ISPR Ispire Technology Inc. 0.10 Bn -2.76 1.08 0.00 Bn
8 GNLN Greenlane Holdings, Inc. 0.03 Bn -2.81 7.16 -